With more than 1.8 million children in the U.S. being treated annually with drugs for attention deficit hyperactivity disorder (ADHD), the possibility that such drugs could damage their hearts has been a significant cause of concern for parents and physicians alike. Now, the results of a long-term National Institutes of Health (NIH)-funded study published last month in Pediatric Research could allay many of those concerns.